Meta-analysis indicates that the overexpression of ANO1 is strongly correlated with poor prognosis and reduced long-term survival in several epithelial-derived malignancies, including breast cancer, HNSCC, ESCC, and CRC (157). Here, ANO1 is linked to colorectal carcinoma.